Skip to main content

Table 6 Short- and long-term outcomes

From: Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution

Ā 

CA19-9ā€‰<ā€‰428 (nā€‰=ā€‰123)

CA19-9ā€‰ā‰„ā€‰428 (nā€‰=ā€‰57)

P-value

Postoperative complications

47 (38.2%)

36 (63.2%)

ā€‰<ā€‰0.005

POPF

16 (13.0%)

25 (43.9%)

ā€‰<ā€‰0.0001

Hospital stay (days)

40.6ā€‰Ā±ā€‰2.1

44.7ā€‰Ā±ā€‰3.0

0.07

In-hospital mortality

3

0

Ā 

Adjuvant chemotherapy

101 (82.1%)

46 (80.7%)

0.82

Median DFS (m)

23

8

ā€‰<ā€‰0.0001

5-year DFS

36.50%

13%

Median OS (m)

56

18

ā€‰<ā€‰0.0001

5-year OS

43.40%

15.40%